AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionUsca Ria Llc
Latest Disclosed Ownership162,927 shares
Latest Disclosed Value $ 18,352,000
Usca Ria Llc reports 3.15% increase in ownership of ABBV / AbbVie Inc.

On July 28, 2021 - Usca Ria Llc filed a 13F-HR form disclosing ownership of 162,927 shares of AbbVie Inc. (US:ABBV) valued at $18,352,097 USD as of June 30, 2021. The entity filed a previous 13F-HR on April 27, 2021 disclosing 157,950 shares of AbbVie Inc.. This represents a change in shares of 3.15% during the quarter. The current value of the position is $37,021,902 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2021-07-28 2021-06-30 13F ABBVIE COM 00287Y109 162,927 4,977 3.15 18,352 7.37 1.1134
2021-04-27 2021-03-31 13F ABBVIE COM 00287Y109 157,950 18,535 13.29 17,093 14.43 1.1237
2021-01-27 2020-12-31 13F ABBVIE COM 00287Y109 139,415 -8,569 -5.79 14,938 15.24 1.0487
2020-10-27 2020-09-30 13F ABBVIE COM 00287Y109 147,984 -25,217 -14.56 12,962 -23.78 1.0161
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 173,201 3,180 1.87 17,005 31.27 1.5044
2020-04-22 2020-03-31 13F/A-2 ABBVIE COM 00287Y109 170,021 41,437 32.23 12,954 13.78 1.5024
2020-04-22 2020-03-31 13F/A-1 ABBVIE COM 00287Y109 103,331 -66,690 7,873 0.4925
2020-01-27 2019-12-31 13F ABBVIE COM 00287Y109 128,584 -29,972 -18.90 11,385 -5.17 1.0183
2019-11-07 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 158,556 -9,453 -5.63 12,006 -1.74 1.1802
2019-10-31 2019-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 158,556 -9,453 12,006 1,145,732.5040
2019-08-14 2019-06-30 13F/A-1 ABBVIE COM 00287Y109 168,009 50,317 42.75 12,218 28.81 1.2402
2019-08-02 2019-06-30 13F ABBVIE COM 00287Y109 168,009 168,009 12,218
2019-08-14 2019-03-31 13F/A-1 ABBVIE COM 00287Y109 117,692 32,627 38.36 9,485 20.95 1.0319
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 85,065 -8,224 -8.82 7,842 -11.12 1.0433
2018-11-02 2018-09-30 13F ABBVIE COM 00287Y109 93,289 -23,026 -19.80 8,823 -18.13 0.8986
2018-08-08 2018-06-30 13F ABBVIE COM 00287Y109 116,315 -10,614 -8.36 10,777 -10.30 1.1575
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 126,929 28,674 29.18 12,014 26.44 1.3234
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 98,255 -56,201 -36.39 9,502 -15.16 1.0487
2017-11-07 2017-09-30 13F ABBVIE COM 00287Y109 154,456 0 0.00 11,200 0.00 1.4490
2017-08-07 2017-06-30 13F ABBVIE COM 00287Y109 154,456 22,872 17.38 11,200 30.63 1.4346
2017-05-01 2017-03-31 13F ABBVIE COM 00287Y109 131,584 9,379 7.67 8,574 12.05 1.2574
2017-02-09 2016-12-31 13F ABBVIE COM 00287Y109 122,205 78,964 182.61 7,652 180.60 1.1778
2016-11-15 2016-09-30 13F ABBVIE COM 00287Y109 43,241 -73,068 -62.82 2,727 -62.13 0.4518
2016-08-13 2016-06-30 13F ABBVIE COM 00287Y109 116,309 18,101 18.43 7,201 28.36 1.2099
2016-05-23 2016-03-31 13F/A-1 ABBVIE COM 00287Y109 98,208 59,757 155.41 5,610 146.27 1.0176
2016-05-16 2016-03-31 13F ABBVIE COM 00287Y109 5,609,620 98,208
2016-02-08 2015-12-31 13F ABBVIE COM 00287Y109 38,451 -792 -2.02 2,278 6.70 0.4921
2015-11-13 2015-09-30 13F ABBVIE COM 00287Y109 39,243 5,228 15.37 2,135 -6.56 0.5359
2015-09-17 2015-06-30 13F/A-1 ABBVIE COM 00287Y109 34,015 1,096 3.33 2,285 18.58 0.6058
2015-08-12 2015-06-30 13F ABBVIE COM 00287Y109 53,785 2,765
2015-09-17 2015-03-31 13F/A-1 ABBVIE COM 00287Y109 32,919 -26,720 -44.80 1,927 -50.63 0.5165
2015-06-03 2015-03-31 13F ABBVIE COM 00287Y109 53,785 2,765
2015-02-11 2014-12-31 13F ABBVIE COM 00287Y109 59,639 -6,362 -9.64 3,903 2.39 1.0780
2014-11-14 2014-09-30 13F ABBVIE COM 00287Y109 66,001 6,573 11.06 3,812 13.66 1.1617
2014-08-28 2014-06-30 13F ABBVIE COM 00287Y109 59,428 5,643 10.49 3,354 21.30 1.1246
2014-05-12 2014-03-31 13F ABBVIE COM 00287Y109 53,785 8,225 18.05 2,765 14.92 0.9932
2014-02-05 2013-12-31 13F ABBVIE COM 00287Y109 45,560 6,725 17.32 2,406 38.51 0.9603
2013-11-14 2013-09-30 13F ABBVIE COM 00287Y109 38,835 16,852 76.66 1,737 91.09 0.7903
2013-08-19 2013-06-30 13F ABBVIE COM 00287Y109 21,983 21,983 909 0.4566
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.